Vaccination News Home Page

http://www.nature.com/cgi-taf/DynaPage.taf?file=/bjc/journal/v87/n11/abs/6600602ab.html

18 November 2002, Volume 87, Number 11, Pages 1257-1266
Table of contents    Previous  Abstract  Next   Full text  PDF
Space
Epidemiology
Exposure to power frequency electric fields and the risk of childhood cancer in the UK
Space
J Skinner1, T J Mee2, R P Blackwell2, M P Maslanyj2, J Simpson3, S G Allen2, N E Day1,a and United Kingdom Childhood Cancer Study Investigators writing committee
Space
1Strangeways Research Laboratory, University of Cambridge, Wort's Causeway, Cambridge CB1 8RN, UK

2National Radiological Protection Board, Chilton, Oxfordshire OX11 0RQ, UK

3Leukaemia Fund Research Centre for Clinical Epidemiology, University of Leeds, 30 Hyde Terrace, Leeds LS2 9LN, UK

Space
Correspondence to: Professor N Day, Strangeways Research Laboratory, University of Cambridge, Wort's Causeway, Cambridge CB1 8RN, UK; E-mail: nick.day@srl.cam.ac.uk
Space
aA list of principal investigators can be found in the Acknowledgements section. A complete list of investigators is to be found in: The United Kingdom Childhood Cancer Study: objectives, material, and methods. Br J Cancer 82(2): 1073-1102
Space
Abstract
Space

The United Kingdom Childhood Cancer Study, a population-based case-control study covering the whole of Great Britain, incorporated a pilot study measuring electric fields. Measurements were made in the homes of 473 children who were diagnosed with a malignant neoplasm between 1992 and 1996 and who were aged 0-14 at diagnosis, together with 453 controls matched on age, sex and geographical location. Exposure assessments comprised resultant spot measurements in the child's bedroom and the family living-room. Temporal stability of bedroom fields was investigated through continuous logging of the 48-h vertical component at the child's bedside supported by repeat spot measurements. The principal exposure metric used was the mean of the pillow and bed centre measurements. For the 273 cases and 276 controls with fully validated measures, comparing those with a measured electric field exposure 20 V m-1 to those in a reference category of exposure <10 V m-1, odds ratios of 1.31 (95% confidence interval 0.68-2.54) for acute lymphoblastic leukaemia, 1.32 (95% confidence interval 0.73-2.39) for total leukaemia, 2.12 (95% confidence interval 0.78-5.78) for central nervous system cancers and 1.26 (95% confidence interval 0.77-2.07) for all malignancies were obtained. When considering the 426 cases and 419 controls with no invalid measures, the corresponding odds ratios were 0.86 (95% confidence interval 0.49-1.51) for acute lymphoblastic leukaemia, 0.93 (95% confidence interval 0.56-1.54) for total leukaemia, 1.43 (95% confidence interval 0.68-3.02) for central nervous system cancers and 0.90 (95% confidence interval 0.59-1.35) for all malignancies. With exposure modelled as a continuous variable, odds ratios for an increase in the principal metric of 10 V m-1 were close to unity for all disease categories, never differing significantly from one.

British Journal of Cancer (2002) 87, 1257-1266. doi:10.1038/sj.bjc.6600602

www.bjcancer.com

 

Ó 2002 Cancer Research UK

Space
Keywords
Space
electric fields; childhood cancer; leukaemia
 
Space
Space
Space
Received 30 May 2002; revised 16 August 2002; accepted 30 August 2002
Space
18 November 2002, Volume 87, Number 11, Pages 1257-1266
Table of contents    Previous  Abstract  Next   Full text  PDF
© 2002 Cancer Research UK

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.